Orexigen Therapeutics

OCTRI: Oregon's CTSA @OHSUoctri·

BIP Corp is a 5-week course for life science innovators to advance their technology to clinical practice. This no-cost course is led by national NSF & NIH experts. OHSU partners & community members welcome! Enroll by 9/3. https://bit.ly/3eRE3R8 #CTSAProgram @OHSUNews @OHSU_Tech

OBI @OTRADIBio·

A #malaria vaccine is in development by @BioNTech_Group. Great news toward ending malaria! Thank you for sharing, @HemexHealth.

#vaccinessavelives

OBI @OTRADIBio·

27 Jul

There's still time to register for today's @OTRADIBio Virtual Lunch & Learn: Accelerating Global Pharma Licensing & Financing, presented by Gemseki. https://www.eventbrite.com/e/lunch-learn-accelerating-global-pharma-licensing-and-financing-registration-157861966391
#Pharmaceutical #Licensing #OBI4You

Orexigen Therapeutics

Twitter

Contact Us

Recent News